ILLUMINA INC (1ILMN.MI) Stock Fundamental Analysis

BIT:1ILMN • US4523271090

104.44 EUR
+1.24 (+1.2%)
Last: Nov 4, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall 1ILMN gets a fundamental rating of 6 out of 10. We evaluated 1ILMN against 18 industry peers in the Life Sciences Tools & Services industry. 1ILMN gets an excellent profitability rating and is at the same time showing great financial health properties. 1ILMN has a decent growth rate and is not valued too expensively. These ratings would make 1ILMN suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year 1ILMN was profitable.
  • In the past year 1ILMN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: 1ILMN reported negative net income in multiple years.
  • 1ILMN had a positive operating cash flow in each of the past 5 years.
1ILMN.MI Yearly Net Income VS EBIT VS OCF VS FCF1ILMN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

  • 1ILMN has a Return On Assets of 11.38%. This is amongst the best in the industry. 1ILMN outperforms 94.74% of its industry peers.
  • 1ILMN has a better Return On Equity (29.53%) than 94.74% of its industry peers.
  • 1ILMN has a Return On Invested Capital of 15.57%. This is amongst the best in the industry. 1ILMN outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROIC 15.57%
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1ILMN.MI Yearly ROA, ROE, ROIC1ILMN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • Looking at the Profit Margin, with a value of 16.39%, 1ILMN belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
  • 1ILMN's Operating Margin of 20.41% is amongst the best of the industry. 1ILMN outperforms 89.47% of its industry peers.
  • 1ILMN's Operating Margin has declined in the last couple of years.
  • 1ILMN's Gross Margin of 66.74% is amongst the best of the industry. 1ILMN outperforms 94.74% of its industry peers.
  • 1ILMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
1ILMN.MI Yearly Profit, Operating, Gross Margins1ILMN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • 1ILMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, 1ILMN has about the same amount of shares outstanding.
  • The number of shares outstanding for 1ILMN has been increased compared to 5 years ago.
  • 1ILMN has a worse debt/assets ratio than last year.
1ILMN.MI Yearly Shares Outstanding1ILMN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1ILMN.MI Yearly Total Debt VS Total Assets1ILMN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • 1ILMN has an Altman-Z score of 4.11. This indicates that 1ILMN is financially healthy and has little risk of bankruptcy at the moment.
  • 1ILMN has a Altman-Z score of 4.11. This is amongst the best in the industry. 1ILMN outperforms 84.21% of its industry peers.
  • 1ILMN has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
  • 1ILMN's Debt to FCF ratio of 1.99 is amongst the best of the industry. 1ILMN outperforms 94.74% of its industry peers.
  • A Debt/Equity ratio of 0.42 indicates that 1ILMN is not too dependend on debt financing.
  • The Debt to Equity ratio of 1ILMN (0.42) is better than 84.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Altman-Z 4.11
ROIC/WACC1.54
WACC10.08%
1ILMN.MI Yearly LT Debt VS Equity VS FCF1ILMN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.43 indicates that 1ILMN should not have too much problems paying its short term obligations.
  • The Current ratio of 1ILMN (1.43) is comparable to the rest of the industry.
  • 1ILMN has a Quick Ratio of 1.12. This is a normal value and indicates that 1ILMN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of 1ILMN (1.12) is better than 63.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.12
1ILMN.MI Yearly Current Assets VS Current Liabilites1ILMN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 152.02% over the past year.
  • 1ILMN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.93% yearly.
  • 1ILMN shows a decrease in Revenue. In the last year, the revenue decreased by -2.32%.
  • The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%

3.2 Future

  • 1ILMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.99% yearly.
  • Based on estimates for the next years, 1ILMN will show a small growth in Revenue. The Revenue will grow by 3.93% on average per year.
EPS Next Y93.48%
EPS Next 2Y43.68%
EPS Next 3Y33.01%
EPS Next 5Y24.99%
Revenue Next Year-1.07%
Revenue Next 2Y0.57%
Revenue Next 3Y2.22%
Revenue Next 5Y3.93%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1ILMN.MI Yearly Revenue VS Estimates1ILMN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
1ILMN.MI Yearly EPS VS Estimates1ILMN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 27.93 indicates a quite expensive valuation of 1ILMN.
  • The rest of the industry has a similar Price/Earnings ratio as 1ILMN.
  • When comparing the Price/Earnings ratio of 1ILMN to the average of the S&P500 Index (26.68), we can say 1ILMN is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 24.05, 1ILMN is valued on the expensive side.
  • 1ILMN's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. 1ILMN is around the same levels.
Industry RankSector Rank
PE 27.93
Fwd PE 24.05
1ILMN.MI Price Earnings VS Forward Price Earnings1ILMN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1ILMN's Enterprise Value to EBITDA is on the same level as the industry average.
  • 73.68% of the companies in the same industry are more expensive than 1ILMN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.7
EV/EBITDA 16.68
1ILMN.MI Per share data1ILMN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1ILMN has a very decent profitability rating, which may justify a higher PE ratio.
  • 1ILMN's earnings are expected to grow with 33.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y43.68%
EPS Next 3Y33.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • 1ILMN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ILLUMINA INC

BIT:1ILMN (11/4/2025, 7:00:00 PM)

104.44

+1.24 (+1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-30
Earnings (Next)02-04
Inst Owners102.96%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap16.05B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts72.86
Price Target97.42 (-6.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)3.23%
PT rev (3m)3.23%
EPS NQ rev (1m)4.77%
EPS NQ rev (3m)4.77%
EPS NY rev (1m)9.83%
EPS NY rev (3m)9.83%
Revenue NQ rev (1m)2.27%
Revenue NQ rev (3m)2.27%
Revenue NY rev (1m)1.07%
Revenue NY rev (3m)1.07%
Valuation
Industry RankSector Rank
PE 27.93
Fwd PE 24.05
P/S 4.36
P/FCF 18.7
P/OCF 16.66
P/B 7.85
P/tB 17.93
EV/EBITDA 16.68
EPS(TTM)3.74
EY3.58%
EPS(NY)4.34
Fwd EY4.16%
FCF(TTM)5.59
FCFY5.35%
OCF(TTM)6.27
OCFY6%
SpS23.95
BVpS13.3
TBVpS5.83
PEG (NY)0.3
PEG (5Y)N/A
Graham Number33.45
Profitability
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROCE 20.76%
ROIC 15.57%
ROICexc 22.34%
ROICexgc 41.04%
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
FCFM 23.32%
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Debt/EBITDA 0.86
Cap/Depr 44.36%
Cap/Sales 2.85%
Interest Coverage 250
Cash Conversion 97.57%
Profit Quality 142.25%
Current Ratio 1.43
Quick Ratio 1.12
Altman-Z 4.11
F-Score7
WACC10.08%
ROIC/WACC1.54
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y93.48%
EPS Next 2Y43.68%
EPS Next 3Y33.01%
EPS Next 5Y24.99%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-1.07%
Revenue Next 2Y0.57%
Revenue Next 3Y2.22%
Revenue Next 5Y3.93%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year30.85%
EBIT Next 3Y15.15%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%

ILLUMINA INC / 1ILMN.MI FAQ

What is the ChartMill fundamental rating of ILLUMINA INC (1ILMN.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1ILMN.MI.


Can you provide the valuation status for ILLUMINA INC?

ChartMill assigns a valuation rating of 4 / 10 to ILLUMINA INC (1ILMN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for ILLUMINA INC?

ILLUMINA INC (1ILMN.MI) has a profitability rating of 4 / 10.


What is the valuation of ILLUMINA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ILLUMINA INC (1ILMN.MI) is 27.93 and the Price/Book (PB) ratio is 7.85.